Mark A. Goldsmith - 03 Jun 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
03 Jun 2024
Net transactions value
-$269,267
Form type
4
Filing time
05 Jun 2024, 16:18:51 UTC
Previous filing
12 Apr 2024
Next filing
20 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $30,675 +7,500 +2.3% $4.09* 329,822 03 Jun 2024 Direct F1, F2, F3
transaction RVMD Common Stock Sale $35,182 -900 -0.27% $39.09 328,922 03 Jun 2024 Direct F1, F2, F3, F4
transaction RVMD Common Stock Sale $227,880 -5,699 -1.7% $39.99 323,223 03 Jun 2024 Direct F1, F2, F3, F5
transaction RVMD Common Stock Sale $36,881 -901 -0.28% $40.93 322,322 03 Jun 2024 Direct F1, F2, F3, F6
holding RVMD Common Stock 30,424 03 Jun 2024 Trust F7
holding RVMD Common Stock 30,424 03 Jun 2024 Trust F8
holding RVMD Common Stock 465,604 03 Jun 2024 Trust F2, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -7,500 -2.3% $0.000000 316,229 03 Jun 2024 Common Stock 7,500 $4.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023.
F2 Reflects the transfer of 138,057 shares previously held directly by the Reporting Person into a family trust.
F3 Includes 232,000 restricted stock units.
F4 This transaction was executed in multiple trades in prices ranging from $38.41 to $39.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 This transaction was executed in multiple trades in prices ranging from $39.41 to $40.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 This transaction was executed in multiple trades in prices ranging from $40.50 to $41.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7 Held by Jonathan Goldsmith Revocable Trust, previously Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F8 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F9 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer